超过5%股东持股披露
Alto Neuroscience(ANRO)03-30 01:05
$Alto Neuroscience(ANRO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-041071 Act: 34 Size: 77 KB 网页链接
简介：Alto Neuroscience, Inc.于2019年3月25日在特拉华州注册成立。公司总部设在加州洛斯阿尔托斯。该公司是一家临床阶段的生物制药公司，其使命是通过利用神经生物学来开发个性化和高效的治疗方案，重新定义精神病学。在其创始人Amit Etkin博士十多年的研究基础上，他们的目标是深入了解大脑功能，并通过使用针对特定患者群体的治疗方法，更有效地为患者匹配正确的药物。他们目前的产品线包括五个临床阶段的资产，最初针对重度抑郁症(MDD)和精神分裂症人群，这些人群具有独立的基于大脑的生物标志物。他们的每一种临床阶段候选产品都至少通过初始1期临床试验进行评估，并观察到耐受性良好。该公司最先进的项目，包括正在进行的后期(2b或更晚)试验评估的两个候选产品，都得到了生物标志物特征人群临床活性的前瞻性重复证据的支持。
| 今开：9.8 | 昨收：9.84 |
| 最高：10.1 | 最低：9.4 |
| 涨停价： | 跌停价： |
| 总市值：266958021 |
Alto Neuroscience(ANRO)03-30 01:05
$Alto Neuroscience(ANRO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-041071 Act: 34 Size: 77 KB 网页链接
Alto Neuroscience(ANRO)05-23 05:25
$Alto Neuroscience(ANRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014118 Size: 5 KB 网页链接
Alto Neuroscience(ANRO)05-23 05:25
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-014115 Size: 11 KB 网页链接
Alto Neuroscience(ANRO)05-15 04:35
$Alto Neuroscience(ANRO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001999480-24-000020 Act: 34 Size: 218 KB 网页链接
Alto Neuroscience(ANRO)04-02 04:46
$Alto Neuroscience(ANRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009533 Size: 6 KB 网页链接
Alto Neuroscience(ANRO)05-21 20:35
$Alto Neuroscience(ANRO)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-143369 Act: 34 Size: 152 KB 网页链接
Alto Neuroscience(ANRO)05-15 04:35
$Alto Neuroscience(ANRO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001999480-24-000022 Act: 34 Size: 7 MB 网页链接
Alto Neuroscience(ANRO)02-03 05:55
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-002344 Size: 17 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 19:15
$Alto Neuroscience(ANRO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000286 Act: 33 Size: 1 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 08:05
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-002217 Size: 9 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 07:55
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-002210 Size: 13 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 07:55
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-002213 Size: 16 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 07:55
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-002211 Size: 16 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 07:55
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000902664-24-000914 Size: 13 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 07:55
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-002212 Size: 13 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 07:55
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001206774-24-000070 Size: 6 KB 网页链接查看全文
Alto Neuroscience(ANRO)02-02 07:55
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-002209 Size: 16 KB 网页链接查看全文
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-014115 Size: 11 KB 网页链接
$Alto Neuroscience(ANRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014118 Size: 5 KB 网页链接
$Alto Neuroscience(ANRO)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-143369 Act: 34 Size: 152 KB 网页链接
$Alto Neuroscience(ANRO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001999480-24-000020 Act: 34 Size: 218 KB 网页链接
$Alto Neuroscience(ANRO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001999480-24-000022 Act: 34 Size: 7 MB 网页链接
$Alto Neuroscience(ANRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009533 Size: 6 KB 网页链接
$Alto Neuroscience(ANRO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-041071 Act: 34 Size: 77 KB 网页链接
$Alto Neuroscience(ANRO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001999480-24-000010 Act: 34 Size: 18 MB 网页链接
$Alto Neuroscience(ANRO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001999480-24-000008 Act: 34 Size: 81 KB 网页链接
$Alto Neuroscience(ANRO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-007641 Size: 9 KB 网页链接